ColonSentry
-
Jack Lifton with StageZero’s James Howard-Tripp on the advantages of non-invasive cancer diagnostic testing
In a recent InvestorIntel interview, Jack Lifton speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
Early identification of colon cancer blood test places healthcare in patients hands
In the news release announced this morning about one of the first blood tests to aid in the early…
